Rhythm Pharmaceuticals, Inc. (RYTM) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Rhythm Pharmaceuticals, Inc. (RYTM) Earnings Overview
As of June 23, 2026, Rhythm Pharmaceuticals, Inc. (RYTM) reported trailing twelve-month net income of -$204M, reflecting +28.3% year-over-year growth. The company earned $-3.00 per diluted share over the past four quarters, with a net profit margin of -103.6%.
Looking at the long-term picture, RYTM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2014.
Rhythm Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HALO ($349M net income, 22.7% margin), RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), RYTM has room to improve margins relative to the peer group. Compare RYTM vs HALO →
RYTM Earnings vs Peers
Earnings metrics vs comparable public companies
RYTM Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$197M | +24.6% | -$192M | $-3.11 | -103.6% | -101.2% |
| 2024 | -$261M | -41.1% | -$266M | $-4.34 | -200.3% | -204.0% |
| 2023 | -$185M | -2.0% | -$184M | $-3.20 | -238.5% | -238.1% |
| 2022 | -$181M | -160.2% | -$179M | $-3.51 | -766.2% | -757.9% |
| 2021 | -$70M | +46.8% | -$170M | $-1.37 | -2207.1% | -5391.9% |
| 2020 | -$131M | +2.9% | -$137M | $-2.96 | - | - |
| 2019 | -$135M | -81.8% | -$146M | $-3.70 | - | - |
| 2018 | -$74M | -119.7% | -$78M | $-2.39 | - | - |
| 2017 | -$34M | -30.3% | -$32M | $-1.26 | - | - |
| 2016 | -$26M | -133.6% | -$26M | $-1.55 | - | - |
| 2015 | -$11M | -70.5% | -$11M | $-1.09 | - | - |
| 2014 | -$6M | +69.7% | -$6M | $-0.64 | - | - |
| 2013 | -$21M | -18.2% | -$21M | $-0.43 | - | - |
| 2012 | -$18M | - | -$18M | $-0.36 | - | - |
Download Data
Export RYTM earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RYTM — Frequently Asked Questions
Quick answers to the most common questions about buying RYTM stock.
What is RYTM earnings per share (EPS)?
RYTM trailing twelve-month (TTM) diluted EPS is $-3.00, reflecting +28.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Rhythm Pharmaceuticals, Inc.'s net income?
Rhythm Pharmaceuticals, Inc. (RYTM) trailing twelve-month net income is $-204M as of 2025. Earnings grew +28.3% year-over-year.
Is RYTM profitable?
RYTM is not currently profitable on a TTM basis, reporting a net loss of $-204M. Net margin is -103.6%. Investors should monitor for a return to profitability.
What is RYTM's earnings growth rate?
RYTM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are RYTM's profit margins?
Rhythm Pharmaceuticals, Inc. net profit margin is -103.6%, operating margin is -101.2%, and gross margin is +89.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -129.5%.
Is RYTM growing earnings?
Yes, RYTM earnings are accelerating — EPS growth of +28.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-204M. Earnings momentum is strengthening.
What was RYTM's best earnings year?
Rhythm Pharmaceuticals, Inc.'s highest annual net income on record is $-6M, achieved in fiscal year 2014. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were RYTM's earnings last quarter?
RYTM's most recent reported quarter was Q1 2026. Net income was $-57M with diluted EPS of $-0.83. For a full breakdown of all quarters, see the quarterly earnings table on this page.